Navigation Links
Varian Medical Systems Schedules Third Quarter FY2009 News Release and Conference Call
Date:6/23/2009

eb conferences will be archived on the company website for a year.

For automatic "e-mail alerts" regarding Varian news and events, investors can subscribe on the company website: http://varian.investorroom.com/index.php?s=58.

For additional information contact Birgit Myles at 650-424-6637 or birgit.myles@varian.com.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 79 offices and facilities around the world. For more information, visit http://www.varian.com/.

    FOR INFORMATION CONTACT:
    Spencer Sias, (650) 424-5782
    Vice President, Corporate Communications
    and Investor Relations
    spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
2. Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
3. Ovarian Cancer Breakthrough Heralds New Era of Treatment
4. Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan
5. Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer
6. New Insights, Inroads Against Breast, Ovarian Cancers
7. New Fast and Precise Treatment Planning System Among Varian Medical Systems Highlights at American Brachytherapy Society 2009 Meeting
8. Dream team targets key driver for breast, ovarian, endometrial cancers
9. Varian Medical Systems Introduces the PaxScan 3030+ X-Ray Image Detector for Interventional Angiography
10. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO
11. The Diagnosis Every Woman Dreads - Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Yesterday, ... Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were honored ... leadership in advancing biotechnology, biomedical science, medical device ... Olsen each received the “2014 Life Sciences Champion” ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 EBSCO Information ... (AMA) are expanding their relationship in an effort to further ... the world. While EBSCO has long made AMA journals available ... sales agent for The JAMA Network. , Long ...
(Date:1/22/2015)... Step into a macabre world where plants ... Virginia. Wicked Plants, the Museum’s latest featured exhibition, opens ... carnivorous and diabolical plants inside of a dilapidated, Victorian ... biochemical, physical and neurological processes between botanicals and the ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... Enable Greater Online ... between Physicians and Patients, ORLANDO, Fla., Feb. ... Conference, Allscripts, the leading provider of,clinical software, connectivity ... announced a collaboration between the National,ePrescribing Patient Safety ...
... It was announced that the,U.S. Court of Federal ... in favor of a child who regressed into ... contained the mercury-based preservative,thimerosal., Case documents state ... an underlying condition that ultimately led to,regressive encephalopathy ...
... There is a wealth of scientific literature available on ... there is a paucity of data to guide the ... the U.S. Food and Drug Administration (FDA) has recently ... with schizophrenia, few controlled data are available to help ...
... Ky., Feb. 28 Anthem Blue Cross and ... a 2007 BlueWorks(R),winner. A program of the Blue ... ways Blue Cross and Blue Shield companies are,working ... delivery,nationwide. The Harvard Medical School Department of Health ...
... has entered,into an agreement with VISICU, Inc., to ... remote monitoring tools, eICU,technology enables off-site critical care ... the clock. The voice, video and data,technology has ... and shorten hospital length of stay., A ...
... emerges from an altered pattern of brain development, and ... the brain to develop along a path that ultimately ... to be published in Biological Psychiatry on March 1st, ... to schizophrenia. , A prior genetic mapping study indicated ...
Cached Medicine News:Health News:The National ePrescribing Patient Safety Initiative Collaborates With Google 2Health News:The National ePrescribing Patient Safety Initiative Collaborates With Google 3Health News:The National ePrescribing Patient Safety Initiative Collaborates With Google 4Health News:Government Concludes Vaccines Caused Autism 2Health News:Comparison of antipsychotic treatments in adolescents with schizophrenia 2Health News:Anthem Blue Cross and Blue Shield's Member Health Index Named BlueWorks(R) Award Winner 2Health News:Anthem Blue Cross and Blue Shield's Member Health Index Named BlueWorks(R) Award Winner 3Health News:The Christ Hospital and VISICU Sign Agreement to Implement eICU(R) Program 2Health News:New genetic association with schizophrenia found by researchers 2
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... Emdeon (NYSE: EM ), a leading provider of healthcare ... participate in the Piper Jaffray Annual Health Care Conference to be ... The "fireside chat", featuring Tracy Bahl, executive chairman, will begin at ... live audio webcast will be available in the Investors section of ...
... , BURLINGTON, Mass., Nov. 17 Palomar Medical ... announce the immediate availability of the Groove Optic for ... significant advancement in fractional ablative skin resurfacing by creating ... ablative tissue coverage while preserving the benefits of fractional ...
Cached Medicine Technology:New! The Groove Optic(TM) for the Lux2940(TM): A Breakthrough in Fractional Skin Resurfacing 2New! The Groove Optic(TM) for the Lux2940(TM): A Breakthrough in Fractional Skin Resurfacing 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: